US Stem Cell Inc (USRM)

[GoldenMind]

$65,133,055 in R&D Cumulative Period from August 12,1999 (date of inception) toSeptember 30,2009 link at bottom

$USRM took some hard hits this quarterly toward operational expenses, but next one is gonna be record breaking and would love to hear someone disagree.

There was the loss on litigation settlement below:
On March 1, 2017, we settled outstanding litigation with Northstar Biotech Group, LLC whereby we issued 10,000,000 and will issue 1,000,000 (an aggregate of 11,000,000) shares of our common stock at a fair value of $316,800. Accordingly, we recorded in operations a loss on litigation settlement of $316,800 for the three months ended March 31, 2017.

which cost them -$316,000 in their operations, WHICH isn't included in COGS, not to mention the pay off of all the debt costing most of their operational expenses under their Add'l Income/Expense Items.

$USRM will see increased revenues through more training services along with actual product now that clinics are expanding..187% growth in services revenue and the first of 10 new clinics just opened up in Miami....easy money,may become their best store!!!

ASSETS LAST 4 quarters
$283k Jun 2016
$413k Sep 2016
$427 Dec 2016
$1385 Mar 2017

Revenues
$678k Jun 2016
$729k Sep 2016
$964k Dec 2016
$1154k Mar 2017

Cash and Cash Equivalents
$130k Jun 2016
$245k Sep 2016
$270k Dec 2016
$619k Mar 2017


I found a million other amazing things, damn. Smack that ask ;)
https://investorshub.advfn.com/secure/post_reply.aspx?message_id=131926471